ICD-10 Coding for Diabetic Vascular Insufficiency(E11.5, E11.51, E11.51B)
Learn about the ICD-10 coding for diabetic vascular insufficiency, including code E11.51 and E11.52, documentation requirements, and clinical validation.
Complete code families applicable to Diabetic Vascular Insufficiency
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E11.51 | Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene | Use when a patient with type 2 diabetes has peripheral vascular disease without gangrene. |
|
| E11.52 | Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene | Use when a patient with type 2 diabetes has peripheral vascular disease with gangrene. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutDiabetic Vascular Insufficiency
Alternative codes to consider when ruling out similar conditions
Use only if there is explicit documentation stating no causal link to diabetes.
Documentation & Coding Risks
Avoid these common issues when documenting Diabetic Vascular Insufficiency.
Failing to document the link between diabetes and vascular disease
Impact
Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims or reduced reimbursement.
Mitigation
Ensure thorough documentation of the causal relationship.
Using E11.9 instead of E11.51 for diabetic patients with PVD
Impact
Reimbursement: Incorrect coding may lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure documentation links PVD to diabetes and use E11.51.
Documentation of causal relationship
Impact
Audits may focus on whether the documentation supports the coding of diabetic vascular complications.
Mitigation
Ensure all documentation explicitly links vascular issues to diabetes.